Alzheimer's disease: a cell biological perspective.

An almost bewildering number of findings concerning Alzheimer's disease mask the significant recent progress in understanding the molecular basis of some inherited forms of this disease and the proteolytic processing of proteins related to the disease. Alzheimer's disease is an amyloidosis, a condition in which certain proteins or protein fragments precipitate in various tissues as amyloid, fibrillar aggregates with a beta-pleated sheet conformation. Alzheimer's is also characterized by neuritic lesions and cell death. Some rare forms of the disease are now known to arise from a mutation in an amyloidogenic protein. Another recent insight is the discovery of an endosomal-lysosomal processing pathway capable of generating protein fragments that can deposit extracellularly as amyloid fibrils. Key future directions for cellular-based research in Alzheimer's disease include the study of membrane trafficking and the passage of intracellular material to the extracellular milieu, molecular signaling among intracellular compartments, the interaction between organelles and the neuronal cytoskeleton, and the nature of cytoskeletal reorganization after neuronal injury.

[1]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[2]  S. Younkin,et al.  Expression of β amyloid protein precursor mRNAs: Recognition of a novel alternatively spliced form and quantitation in alzheimer's disease using PCR , 1990, Neuron.

[3]  K. Kosik,et al.  Microtubule destabilization and neurofilament phosphorylation precede dendritic sprouting after close axotomy of lamprey central neurons. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. Price,et al.  Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[5]  H. Wiśniewski,et al.  Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. , 1986, The Journal of biological chemistry.

[6]  K. Kosik,et al.  Overexpression of tau in a nonneuronal cell induces long cellular processes , 1991, The Journal of cell biology.

[7]  I. Lieberburg,et al.  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.

[8]  Y. Ihara,et al.  The car☐yl third of tau is tightly bound to paired helical filaments , 1988, Neuron.

[9]  Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau) , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Brion,et al.  Both adult and juvenile tau microtubule-associated proteins are axon specific in the developing and adult rat cerebellum , 1988, Neuroscience.

[11]  R. Neve,et al.  The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects , 1989, Experimental Neurology.

[12]  C. Bouras,et al.  Down patients: Extracellular preamyloid deposits precede neuritic degeneration and senile plaques , 1989, Neuroscience Letters.

[13]  Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[14]  P. Greengard,et al.  Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  I. Krantz,et al.  Coca chewing and cholera , 1991, The Lancet.

[16]  J. Lippincott-Schwartz,et al.  Cycling of the integral membrane glycoprotein, LEP100, between plasma membrane and lysosomes: Kinetic and morphological analysis , 1987, Cell.

[17]  M. Lerman,et al.  Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. , 1987, Science.

[18]  K. Johnson-wood,et al.  The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II , 1989, Nature.

[19]  K. Kosik,et al.  Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons , 1990, Nature.

[20]  D. Graham,et al.  βA4 amyloid protein deposition in brain after head trauma , 1991, The Lancet.

[21]  Carl W. Cotman,et al.  Protease nexin-II, a potent anti-chymotrypsin, shows identity to amyloid β-protein precursor , 1989, Nature.

[22]  B. Greenberg,et al.  A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors , 1988, Nature.

[23]  J. Trojanowski,et al.  Epitopes that span the tau molecule are shared with paired helical filaments , 1988, Neuron.

[24]  R. Neve,et al.  Expression of the Alzheimer amyloid precursor gene transcripts in the human brain , 1988, Neuron.

[25]  K. Kosik,et al.  The effect of tau antisense oligonucleotides on neurite formation of cultured cerebellar macroneurons , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  L. Binder,et al.  Biochemical and immunological analyses of cytoskeletal domains of neurons , 1986, The Journal of cell biology.

[27]  S. Singer,et al.  Cell biology of cytotoxic and helper T cell functions: immunofluorescence microscopic studies of single cells and cell couples. , 1989, Annual review of immunology.

[28]  J. Trojanowski,et al.  Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[29]  K. Kosik,et al.  Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease , 1987, Annals of neurology.

[30]  V. Lee,et al.  Comparative epitope analysis of neuronal cytoskeletal proteins in Alzheimer's disease senile plaque neurites and neuropil threads. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[31]  A. D. Hershey,et al.  Amyloid-beta peptide, substance P, and bombesin bind to the serpin-enzyme complex receptor. , 1991, The Journal of biological chemistry.

[32]  T. Oltersdorf,et al.  Cleavage of amyloid beta peptide during constitutive processing of its precursor. , 1990, Science.

[33]  F. D. de Sauvage,et al.  A novel mRNA of the A4 amyloid precursor gene coding for a possibly secreted protein. , 1989, Science.

[34]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[35]  K. Yoshikawa,et al.  Formation of amyloid-like fibrils in COS cells overexpressing part of the Alzheimer amyloid protein precursor , 1990, Nature.

[36]  D. Selkoe,et al.  Protein chemical and immunocytochemical studies of meningovascular β-amyloid protein in Alzheimer's disease and normal aging , 1988, Brain Research.

[37]  C. Hopkins,et al.  Role of the human transferrin receptor cytoplasmic domain in endocytosis: localization of a specific signal sequence for internalization , 1990, The Journal of cell biology.

[38]  J. Reed,et al.  Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease , 1991 .

[39]  M. Brown,et al.  NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor. , 1990, The Journal of biological chemistry.

[40]  M. Vitek,et al.  A novel species-specific RNA related to alternatively spliced amyloid precursor protein mRNAs , 1991, Neurobiology of Aging.

[41]  D. Holtzman,et al.  Dysregulation of gene expression in mouse trisomy 16, an animal model of Down syndrome. , 1992, The EMBO journal.

[42]  D. Allsop,et al.  The occult aftermath of boxing. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[43]  J. Ávila,et al.  A modified form of microtubule-associated tau protein is the main component of paired helical filaments. , 1988, Biochemical and biophysical research communications.

[44]  D. Dickson,et al.  Alzheimer's neurofibrillary tangles contain unique epitopes and epitopes in common with the heat-stable microtubule associated proteins tau and MAP2. , 1987, The American journal of pathology.

[45]  G. Glenner,et al.  Differences Between Vascular and Plaque Core Amyloid in Alzheimer's Disease , 1988, Journal of neurochemistry.

[46]  P. S. St George-Hyslop,et al.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. , 1987, Science.

[47]  P. Davies,et al.  A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Delacourte,et al.  Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments , 1986, Journal of the Neurological Sciences.

[49]  Jurg Ott,et al.  Linkage of a prion protein missense variant to Gerstmann–Sträussler syndrome , 1989, Nature.

[50]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[51]  H. W. Harris,et al.  Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[52]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[53]  M. Benson,et al.  Familial amyloidotic polyneuropathy , 1989, Trends in Neurosciences.

[54]  J. Ghiso,et al.  In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease β-protein , 1986 .

[55]  P. Fraser,et al.  pH-dependent structural transitions of Alzheimer amyloid peptides. , 1991, Biophysical journal.

[56]  H. Wiśniewski,et al.  Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[57]  K. Kosik,et al.  Processes induced by tau expression in Sf9 cells have an axon-like microtubule organization , 1991, The Journal of cell biology.

[58]  L. Villa-komaroff,et al.  Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease , 1988, Nature.

[59]  B. Ghetti,et al.  A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. , 1991, Science.

[60]  R. Martins,et al.  Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. , 1989, The New England journal of medicine.

[61]  D. Gajdusek Transmissible and non-transmissible amyloidoses: autocatalytic post-translational conversion of host precursor proteins to β-pleated sheet configurations , 1988, Journal of Neuroimmunology.

[62]  N. Kowall,et al.  Thy‐1 in Hippocampus: Normal Anatomy and Neuritic Growth in Alzheimer's Disease , 1992, Journal of neuropathology and experimental neurology.

[63]  H. G. Boman,et al.  Antibacterial peptides: Key components needed in immunity , 1991, Cell.

[64]  B. Frangione,et al.  Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic x-ray diffraction pattern. , 1987, Biochemical and biophysical research communications.

[65]  D. Selkoe,et al.  Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[66]  A. Frankfurter,et al.  The distribution of tau in the mammalian central nervous system , 1985, The Journal of cell biology.

[67]  R. Nixon,et al.  Neurofilament phosphorylation: a new look at regulation and function , 1991, Trends in Neurosciences.

[68]  D. Price,et al.  Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. , 1990, Science.

[69]  H. Y. Chen,et al.  Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. , 1992, The New England journal of medicine.

[70]  S. Hirai,et al.  Expression of APP in the early stage of brain damage , 1991, Brain Research.

[71]  P. Davies,et al.  Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. , 1992, The Journal of biological chemistry.

[72]  D. Selkoe,et al.  Isolation of Low‐Molecular‐Weight Proteins from Amyloid Plaque Fibers in Alzheimer's Disease , 1986, Journal of neurochemistry.

[73]  D. Selkoe,et al.  X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[74]  D. Selkoe,et al.  Identification of a stable fragment of the Alzheimer amyloid precursor containing the beta-protein in brain microvessels. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[75]  Robert B. Nelson,et al.  Expression of β-amyloid precursor protein in reactive astrocytes following neuronal damage , 1989, Neuron.

[76]  J. Trojanowski,et al.  A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. , 1991, Science.

[77]  R. Davis,et al.  Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. , 1991, The Journal of biological chemistry.

[78]  Fred H. Gage,et al.  Intracerebral grafting: A tool for the neurobiologist , 1991, Neuron.

[79]  R. Neve,et al.  Tau in situ hybridization in normal and alzheimer brain: Localization in the somatodendritic compartment , 1989, Annals of neurology.

[80]  R. Ye,et al.  Mutations in the cytoplasmic domain of the 275 kd mannose 6-phosphate receptor differentially alter lysosomal enzyme sorting and endocytosis , 1989, Cell.

[81]  J. Walker,et al.  Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[82]  B. Frangione,et al.  Isolation and Partial Characterization of Neurofibrillary Tangles and Amyloid Plaque Core in Alzheimer's Disease: Immunohistological Studies , 1986, Journal of neuropathology and experimental neurology.

[83]  J. Ghiso,et al.  Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C). , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[84]  M. Ambler,et al.  Post–traumatic Alzheimer's disease: preponderance of a single plaque type , 1991, Neuropathology and applied neurobiology.

[85]  Y. Ihara,et al.  One of the antigenic determinants of paired helical filaments is related to tau protein. , 1986, Journal of biochemistry.

[86]  D. Selkoe,et al.  Alzheimer's disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea. , 1982, Science.

[87]  C. Cotman,et al.  Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. , 1992, The Journal of biological chemistry.

[88]  J. Hardy,et al.  Amyloid precursor protein gene mutation in early-onset Alzheimer's disease , 1991, The Lancet.

[89]  S. Younkin,et al.  Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. , 1992, Science.

[90]  F. Maxfield,et al.  Human transferrin receptor internalization is partially dependent upon an aromatic amino acid on the cytoplasmic domain. , 1990, Cell regulation.

[91]  J. Ghiso,et al.  Amyloidosis due to a mutation of the gelsolin gene in an American family with lattice corneal dystrophy type II. , 1991, The New England journal of medicine.

[92]  C. Barrow,et al.  Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. , 1991, Science.

[93]  K. Kosik,et al.  Neuritic pathology and dementia in alzheimer's disease , 1991, Annals of neurology.

[94]  Stephen J. DeArmond,et al.  Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication , 1990, Cell.

[95]  S. Prusiner,et al.  Molecular biology of prion diseases , 1991, Science.

[96]  S. V. van Duinen,et al.  Expression of a normal and variant Alzheimer's beta-protein gene in amyloid of hereditary cerebral hemorrhage, Dutch type: DNA and protein diagnostic assays. , 1990, Biochemical and biophysical research communications.

[97]  Y. Ihara Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease , 1988, Brain Research.

[98]  D. Selkoe,et al.  Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. , 1992, Science.

[99]  J. Hardy,et al.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene , 1991, Nature.

[100]  D. Dickson,et al.  Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. , 1988, The American journal of pathology.

[101]  I. Mellman,et al.  Fc receptor endocytosis is controlled by a cytoplasmic domain determinant that actively prevents coated pit localization , 1992, The Journal of cell biology.

[102]  L. Refolo,et al.  The Alzheimer amyloid precursor is associated with the detergent- insoluble cytoskeleton , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[103]  I. Trowbridge,et al.  Endocytosis and signals for internalization. , 1991, Current opinion in cell biology.